Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
282.80
-5.49 (-1.90%)
Feb 21, 2025, 4:00 PM EST - Market closed
Insulet Employees
Insulet had 3,000 employees as of December 31, 2023. The number of employees increased by 400 or 15.38% compared to the previous year.
Employees
3,000
Change (1Y)
400
Growth (1Y)
15.38%
Revenue / Employee
$690,533
Profits / Employee
$139,433
Market Cap
19.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
PODD News
- 20 hours ago - Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - Benzinga
- 1 day ago - Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Insulet beats quarterly profit estimates on insulin pump demand - Reuters
- 1 day ago - Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year - Business Wire
- 5 weeks ago - Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe - Business Wire
- 6 weeks ago - Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire
- 2 months ago - Heavy Interest in Insulet's Insulin Delivery Device - FXEmpire
- 2 months ago - Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters